Chemoinformaics analysis of 1,2,3,4,6-PENTA-O-GALLOYL-BETA-D-GLUCOSE
| Molecular Weight | 940.681 | nRot | 11 |
| Heavy Atom Molecular Weight | 908.425 | nRig | 41 |
| Exact Molecular Weight | 940.118 | nRing | 6 |
| Solubility: LogS | -1.682 | nHRing | 1 |
| Solubility: LogP | 2.17 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 5 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 67 | No. of Aromatic Carbocycles | 5 |
| nHetero | 26 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 41 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 30 |
| No. of Oxygen atom | 26 | No. of Arom Bond | 30 |
| nHA | 26 | APOL | 110.659 |
| nHD | 15 | BPOL | 46.8586 |
| QED | 0.051 |
| Synth | 4.753 |
| Natural Product Likeliness | 0.617 |
| NR-PPAR-gamma | 0.339 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.328 |
| Pgp-sub | 0 |
| HIA | 0.999 |
| CACO-2 | -7.222 |
| MDCK | 0.00000829 |
| BBB | 0.001 |
| PPB | 0.833234 |
| VDSS | 0.289 |
| FU | 0.33342 |
| CYP1A2-inh | 0.499 |
| CYP1A2-sub | 0.004 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.011 |
| CYP2c9-inh | 0.243 |
| CYP2c9-sub | 0.009 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.052 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.002 |
| CL | 14.481 |
| T12 | 0.985 |
| hERG | 0.049 |
| Ames | 0.037 |
| ROA | 0 |
| SkinSen | 0.975 |
| Carcinogencity | 0.009 |
| EI | 0.96 |
| Respiratory | 0 |
| NR-Aromatase | 0.332 |
| Antiviral | Yes |
| Prediction | 0.661582 |